✦ LIBER ✦

C145 ANALYSES OF POTENTIAL PREDICTIVE MARKERS FOR A RESPONSE TO SUNITINIB IN PATIENTS WITH METASTATIC RENAL CELL CARCINOMA

✍ Scribed by Dornbusch, J.; Zacharis, A.; Meinhardt, M.; Erdmann, K.; Zastrow, S.; Fuessel, S.; Wirth, M.P.

Book ID: 123098736
Publisher: Elsevier Science
Year: 2012
Tongue: English
Weight: 299 KB
Volume: 11
Category: Article
ISSN: 1569-9056
DOI: 10.1016/S1569-9056(13)60144-X

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

984 Potential predictive markers for a r

984 Potential predictive markers for a response to sunitinib and their association with survival of patients with metastatic renal cell carcinoma

✍ Dornbusch, J.; Meinhardt, M.; Erdmann, K.; Zacharis, A.; Zastrow, S.; Füssel, S. 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 82 KB

Predictive role of tissue-based molecula

Predictive role of tissue-based molecular markers in patients treated with sunitinib for metastatic renal cell carcinoma

✍ You, Dalsan; Song, Sang Hoon; Cho, Yong Mee; Lee, Jae-Lyun; Jeong, In Gab; Song, 📂 Article 📅 2014 🏛 Springer-Verlag 🌐 English ⚖ 231 KB

Prognostic nomogram for sunitinib in pat

Prognostic nomogram for sunitinib in patients with metastatic renal cell carcinoma

✍ Robert J. Motzer; Ronald M. Bukowski; Robert A. Figlin; Thomas E. Hutson; M. Dro 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 115 KB 👁 3 views

## Abstract ## BACKGROUND. In a randomized, phase 3 trial, sunitinib demonstrated superior efficacy over interferon‐alfa as first‐line therapy in patients with metastatic clear‐cell renal cell carcinoma (RCC). On the basis of outcome data from that trial, the authors developed a nomogram for predi

1786 C-REACTIVE PROTEIN AS A MARKER OF T

1786 C-REACTIVE PROTEIN AS A MARKER OF TREATMENT RESPONSE AND PREDICTOR OF PROGNOSIS IN CHINESE METASTATIC RENAL CELL CARCINOMA PATIENTS TREATED WITH SUNITINIB

✍ shi, guohai 📂 Article 📅 2012 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 46 KB

Onset of Male Gynaecomastia in a Patient

Onset of Male Gynaecomastia in a Patient Treated with Sunitinib for Metastatic Renal Cell Carcinoma

✍ Dr Pierluigi Ballardini, Guido Margutti, Camillo Aliberti, Roberto Manfredini 📂 Article 📅 2009 🏛 Springer International Publishing AG 🌐 English ⚖ 118 KB

Sorafenib in patients with metastatic re

Sorafenib in patients with metastatic renal cell carcinoma refractory to either sunitinib or bevacizumab

✍ Jorge A. Garcia; Thomas E. Hutson; Paul Elson; C. Lance Cowey; Timothy Gilligan; 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 249 KB 👁 2 views